In our centre distal ureteral frozen sections during radical cystectomy (RC) for bladder cancer (BC) are routinely performed and repeated, if positive, until the reach of negative samples.
INTRODUCTION AND OBJECTIVES:
In our centre distal ureteral frozen sections during radical cystectomy (RC) for bladder cancer (BC) are routinely performed and repeated, if positive, until the reach of negative samples.
However, despite several studies, there is not a global consensus on the adequate management of positive margins. Especially it is not clear if the positive findings are correlated with oncological outcomes. Aim of our study was to evaluate if the presence of positive ureteral frozen sections (negative at final pathological report) impacts on recurrence and survival outcomes METHODS: We evaluated 391 consecutive patients treated with RC for BC at a single tertiary referral centre between 2008 and 2015. We systematically performed ureteral frozen section independently to the bladder diversion or to TNM status. Univariable and multivariable Cox proportional hazards regression model was used to predict cancer specific mortality (CSM), overall mortality (OM) and recurrence (R). The Kaplan-Meier method was used to compare recurrence, CSM and OM in the overall population. Covariates included age at surgery, gender, pathological T stage, pathological N stage, pathological grade, surgical margins (SM) and lymph vascular invasion (LVI) RESULTS: Median age was 71 years (IQR 40-90 years). 322 patients (82%) were male. Overall, 117 (29,9%), 51(13%) and 174 (44,5%) patients were recorded with lymph node metastases, positive SM and pT3-4 , respectively. CSM was observed in 146 (37%) patients, whereas OM was observed in 194 patients (49%) and R in 154 (39%) patients. Median follow-up was 30 months (IQR 5-109 months). CONCLUSIONS: Ureteral frozen sections should be always performed. Considering the impact on oncological outcomes, positive ureteral frozen sections, even when negative at the final report, should be taken into account in the planning of the follow-up of patients who underwent to RC due to BC Source of Funding: none
MP38-16 JUSTIFICATION OF 8TH EDITION AJCC TUMOR NODE METASTASIS UPDATES FOR BLADDER CANCER STAGING
Marcus Daniels*, Trinity Bivalacqua, Andres Matoso, Max Kates, Baltimore, MD INTRODUCTION AND OBJECTIVES: In 2017, the AJCC updated guidelines for the staging of bladder cancer. The new guidelines subdivided prognostic stage groups 3 and 4 into four groups based on regional lymph node (LN) and metastasis location. In the 7th edition, T3A-T4A N0 M0 were group 3 while group 4 included T4B, N1-3, and M1 patients. In the 8th Edition guidelines: group 3A includes T3A-T4A and N1 patients, group 3B includes N2-3 patients, group 4A includes T4B and M1A patients, and group 4B includes M1B patients. We sought to justify these changes in our institutional cohort.
METHODS: We retrospectively identified radical cystectomy patients with T3A-T4B N0 M0 disease and patients with N1-3 disease at our institution (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) (2016) . Eight or more LN removed was considered appropriate to determine LN status. Patients were stratified according to AJCC 7th and 8th Edition staging. Baseline differences in demographics were compared and Kaplan-Meier curves were constructed to assess recurrence free survival (RFS) and overall survival (OS) between groups. Recurrence was considered unknown if follow up time was less than 1 month.
RESULTS: A total of 333 patients were included in the analysis. No T4B, N3, nor M1 patients were included due to limited sample size. METHODS: A consecutive series of 2395 patients with primitive or recurrent BC treated with RC in 4 centres were evaluated. COBRA score was calculated. The role of COBRA score as predictor of CSS was assessed using the Kaplan Meier and Cox proportional hazards analyses. COBRA score was evaluated either as a continuous and categorical variable. Accuracy of COBRA score was evaluated by Harrell's C test.
RESULTS: Median age was 66 (IQR 58/73) years; 612/2,395 (26%) patients presented a non-organ confined disease (!pT3a), 478/ 2395 (20%) presented positive lymphnodes. Overall, at a median follow-up of 48 (IQR 22/92) months, 642 patients (27%) died of bladder cancer. On Cox proportional hazards analyses, COBRA score was a significant predictor of CSS (HR 1.54, 95%CI 1.47-1.61) ( Table 1) . Kaplan Meier curves are displayed in Figure 1a . The predictive accuracy of the COBRA score was 0.71. A sub analysis including pooled COBRA score (0 vs 1-3 vs 4 vs 5-7) improved the clinical applicability with the same accuracy ( Figure 1b) CONCLUSIONS: In our experience, the COBRA score is an excellent tool to predict cancer specific survival. The COBRA Score represents a practical and easily applicable tool that may help urologists to classify the CSS of patients treated with RC and to predict the oncological outcome.
Source of Funding: none

MP38-18
INTRODUCTION AND OBJECTIVES: Robot assisted radical cystectomy with intracorporeal urinary diversion (ICUD) is growing in utilization with robotic experience. Retrospective data suggests ICUD is safe when performed by an experienced surgeon and may improve operative time and transfusion rate. The effect of ICUD on ureterointestinal anastomotic stricture, however, is not well described. The objective herein is to compare anastomotic stricture between open urinary diversion (OUD) and ICUD.
METHODS: A prospectively maintained database of patients that underwent cystectomy between 2011-2016 was reviewed. OUD included patients with either open cystectomy (OC) or robot assisted radical cystectomy (RARC) with extracorporeal diversion (ECUD). Anastomotic stricture was defined as 1) hydronephrosis with confirmatory testing (MAG3 or loopogram) 2) need for percutaneous drainage with confirmatory imaging or 3) hydronephrosis with progressive renal atrophy without alternative explanation. The incidence of stricture in OUD and ICUD was compared using log-rank analysis with a KaplanMeier curve and a Cox proportional hazard regression to control for age, sex, BMI, pathologic stage, and diversion type.
RESULTS: 632 patients underwent cystectomy for malignancy. 453 underwent OUD (230 OC, 223 RARC with ECUD) and 179 underwent RARC with ICUD. Anastomotic stricture occurred in 54 (11.9%) of OUD and 33 (18.4%) of ICUD (p [ 0.037; figure 1). 10 (11.5%) of obstructions were secondary to malignancy. Mean time to stricture in OUD and ICUD was not significantly different (12.0 and 10.7 months; p [ 0.65). Stricture laterality was not significantly different between groups; in the entire cohort, 54.5% occurred on the left, 30.3% right, and 15.2% bilateral. ICUD (HR 1.78, 1.14-2.81; p [ 0.012) and BMI (HR 1.06, 1.02-1.09; p[ 0.001) remained independently associated with anastomotic stricture on multivariable analysis.
CONCLUSIONS: In our cohort, patients with intracorporeal urinary diversions were nearly 80% more likely to have anastomotic stricture than patients with open diversions. Of note, we did not control for surgeon experience, which may have contributed to stricture incidence. Regardless, as ICUD becomes more common it should be critically assessed as a risk factor for anastomotic stricture and surgical technique may need to be improved.
